Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: Correlation with outcomes

Journal of the American College of Cardiology

Volumn 61, Issue 2, 2013, Pages 196-206

  Metra, Marco ^a   Cotter, Gad ^b   Davison, Beth A ^b   Felker, G Michael ^c   Filippatos, Gerasimos ^d   Greenberg, Barry H ^e   Ponikowski, Piotr ^f   Unemori, Elaine ^g   Voors, Adriaan A ^h   Adams, Kirkwood F ⁱ   Dorobantu, Maria I ^j   Grinfeld, Liliana ^k   Jondeau, Guillaume ^l   Marmor, Alon ^m   Masip, Josep ⁿ   Pang, Peter S ^o   Werdan, Karl ^p   Prescott, Margaret F ^q   Edwards, Christopher ^b   Teichman, Sam L ^g   Trapani, Angelo ^q   Bush, Christopher A ^q   Saini, Rajnish ^q   Schumacher, Christoph ^q   Severin, Thomas ^q   Teerlink, John R ^r   more..

^a UNIVERSITY OF BRESCIA   (Italy)

^b Momentum Research Inc   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

^g Corthera Inc ^*  (United States)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ UNIVERSITY OF NORTH CAROLINA   (United States)

^j Floreasca Emergency Clinical Hospital   (Romania)

^k UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^l BICHAT HOSPITAL   (France)

^m Rebecca Sieff Government Hospital   (Israel)

ⁿ UNIVERSITY OF BARCELONA   (Spain)

^o NORTHWESTERN UNIVERSITY   (United States)

^p MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^q NOVARTIS PHARMA AG   (Switzerland)

^r UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

congestion; heart failure; organ protection; RELAX AHF; serelaxin

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; PLACEBO; RELAXIN; SERELAXIN; TROPONIN T;

ACUTE HEART FAILURE; ARTICLE; BLOOD LEVEL; CAUSE OF DEATH; DISEASE COURSE; DISEASE MARKER; DRUG RESPONSE; FOLLOW UP; HEALTH PROGRAM; HEART INJURY; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LIVER FAILURE; MULTICENTER STUDY (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS;

ACUTE DISEASE; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; DOUBLE-BLIND METHOD; HEART FAILURE; HOSPITALIZATION; HUMANS; KIDNEY; LIVER; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; RELAXIN; SURVIVAL RATE; TREATMENT OUTCOME; TROPONIN T;

EID: 84871927704     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.005     Document Type: Article

References (39)

1. G.C. Fonarow, W.T. Abraham, N.M. Albert Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Arch Intern Med 167 2007 1493 1502
2. S.D. Solomon, J. Dobson, S. Pocock Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure Circulation 116 2007 1482 1487
3. M. Gheorghiade, P.S. Pang Acute heart failure syndromes J Am Coll Cardiol 53 2009 557 573
4. J.J. McMurray, S. Adamopoulos, S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
5. S. Laribi, A. Aouba, M. Nikolaou Trends in death attributed to heart failure over the past two decades in Europe Eur J Heart Fail 14 2012 234 239
6. L.W. Stevenson Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant Circulation 113 2006 1020 1027
7. G. Cotter, M. Metra, O. Milo-Cotter, H.C. Dittrich, M. Gheorghiade Fluid overload in acute heart failure - re-distribution and other mechanisms beyond fluid accumulation Eur J Heart Fail 10 2008 165 169
8. M. Gheorghiade, F. Follath, P. Ponikowski Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine Eur J Heart Fail 12 2010 423 433
9. M. Metra, G. Cotter, M. Gheorghiade, L. Dei Cas, A.A. Voors The role of the kidney in heart failure Eur Heart J 33 2012 2135 2142
10. A.P. Ambrosy, M. Vaduganathan, M.D. Huffman Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial Eur J Heart Fail 14 2012 302 311
11. V.M. van Deursen, K. Damman, H.L. Hillege, A.P. van Beek, D.J. van Veldhuisen, A.A. Voors Abnormal liver function in relation to hemodynamic profile in heart failure patients J Card Fail 16 2010 84 90
12. G. Torre-Amione, O. Milo-Cotter, E. Kaluski Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome J Card Fail 15 2009 639 644
13. M. Metra, J.R. Teerlink, G.M. Felker Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study Eur J Heart Fail 12 2010 1130 1139
14. M. Metra, C.M. O'Connor, B.A. Davison Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT study Eur Heart J 32 2011 1519 1534
15. L.A. Allen, A.F. Hernandez, C.M. O'Connor, G.M. Felker End points for clinical trials in acute heart failure syndromes J Am Coll Cardiol 53 2009 2248 2258
16. S.L. Teichman, E. Unemori, J.R. Teerlink, G. Cotter, M. Metra Relaxin: review of biology and potential role in treating heart failure Curr Heart Fail Rep 7 2010 75 82
17. X.J. Du, R.A. Bathgate, C.S. Samuel, A.M. Dart, R.J. Summers Cardiovascular effects of relaxin: from basic science to clinical therapy Nat Rev Cardiol 7 2010 48 58
18. K.P. Conrad, S.G. Shroff Effects of relaxin on arterial dilation, remodeling, and mechanical properties Curr Hypertens Rep 13 2011 409 420
19. J.R. Teerlink, M. Metra, G.M. Felker Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study Lancet 373 2009 1429 1439
20. P. Ponikowski, M. Metra, J.R. Teerlink Design of the Relaxin in Acute Heart Failure study Am Heart J 163 2012 149 155
21. J.R. Teerlink, G. Cotter, B.A. Davison RELAXin in Acute Heart Failure (RELAX-AHF) Investigators Serelaxin, recombinant human relaxin-2, for the treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial Lancet 2012 Nov 6 [E-pub ahead of print]
22. K. Thygesen, J.S. Alpert, A.S. Jaffe Third universal definition of myocardial infarction Eur Heart J 33 2012 2551 2567
23. K. Thygesen, J. Mair, E. Giannitsis How to use high-sensitivity cardiac troponins in acute cardiac care Eur Heart J 33 2012 2252 2257
24. J.L. Januzzi Jr, G. Filippatos, M. Nieminen, M. Gheorghiade Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section Eur Heart J 33 2012 2265 2271
25. S.S. Gottlieb, W. Abraham, J. Butler The prognostic importance of different definitions of worsening renal function in congestive heart failure J Card Fail 8 2002 136 141
26. J. Lassus, V.P. Harjola, R. Sund Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP Eur Heart J 28 2007 1841 1847
27. P. Bettencourt, A. Azevedo, J. Pimenta, F. Frioes, S. Ferreira, A. Ferreira N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2004 2168 2174
28. A. Maisel, C. Mueller, K. Adams Jr State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
29. G. Cotter, M. Metra, B.D. Weatherley Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure - association with signs and symptoms, hospitalization duration, and 60-day outcomes Cardiology 115 2010 29 36
30. C.M. O'Connor, R.J. Mentz, G. Cotter The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction Eur J Heart Fail 14 2012 605 612
31. A. Laupacis, D.L. Sackett, R.S. Roberts An assessment of clinically useful measures of the consequences of treatment N Engl J Med 318 1988 1728 1733
32. J. Fang, G.A. Mensah, J.B. Croft, N.L. Keenan Heart failure-related hospitalization in the U.S., 1979 to 2004 J Am Coll Cardiol 52 2008 428 434
33. R.D. Kociol, P.S. Pang, M. Gheorghiade, G.C. Fonarow, C.M. O'Connor, G.M. Felker Troponin elevation in heart failure prevalence, mechanisms, and clinical implications J Am Coll Cardiol 56 2010 1071 1078
34. M. Metra, L. Bettari, F. Pagani Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation Clin Res Cardiol 101 2012 663 672
35. C.M. O'Connor, M. Fiuzat, C. Lombardi Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study Circ Heart Fail 4 2011 724 732
36. K. Damman, G. Navis, A.A. Voors Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 2007 599 608
37. G.M. Felker, K.L. Lee, D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
38. G.S. Filippatos, R.V. Desai, M.I. Ahmed Hypoalbuminaemia and incident heart failure in older adults Eur J Heart Fail 13 2011 1078 1086
39. G.S. Filippatos, M.I. Ahmed, J.D. Gladden Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data Eur Heart J 32 2011 712 720